Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor. 2010

Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

The structure of aldehyde reductase (ALR1) in ternary complex with the coenzyme NADPH and [5-(3-carboxymethoxy-4-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid (CMD), a potent inhibitor of aldose reductase (ALR2), was determined at 1.99A resolution. The partially disordered inhibitor formed a tight network of hydrogen bonds with the active site residues (Tyr50 and His113) and coenzyme. Molecular modelling calculations and inhibitory activity measurements of CMD and [5-(3-hydroxy-4-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid (HMD) indicated that pi-stacking interactions with several conserved active site tryptophan residues and hydrogen-bonding interactions with the non-conserved C-terminal residue Leu300 in ALR2 (Pro301 in ALR1) contributed to inhibitor selectivity. In particular for the potent inhibitor CMD, the rotameric state of the conserved residue Trp219 (Trp220 in ALR1) is important in forming a pi-stacking interaction with the inhibitor in ALR2 and contributes to the difference in the binding of the inhibitor to the enzymes.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000449 Aldehyde Reductase An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21. Aldose Reductase,Aldose Reductase Ia,Aldose Reductase Ib,Erythrose Reductase,Xylose Reductase,Reductase Ia, Aldose,Reductase Ib, Aldose,Reductase, Aldehyde,Reductase, Aldose,Reductase, Erythrose,Reductase, Xylose
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045162 Thiazolidinediones THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma). Glitazones
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
February 2006, Bioorganic & medicinal chemistry letters,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
April 2002, Bioorganic & medicinal chemistry,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
April 2005, Bioorganic & medicinal chemistry,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
August 2005, Journal of medicinal chemistry,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
May 2017, Journal of chromatographic science,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
October 1997, Proteins,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
July 2007, Bioorganic & medicinal chemistry letters,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
September 1998, Molecular vision,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
December 2017, Future medicinal chemistry,
Vincenzo Carbone, and Marco Giglio, and Roland Chung, and Trevor Huyton, and Julian Adams, and Rosanna Maccari, and Rosaria Ottana, and Akira Hara, and Ossama El-Kabbani
August 2007, Cellular and molecular life sciences : CMLS,
Copied contents to your clipboard!